MetLife (MET) Form 144 filing details planned 30-share sale
MetLife (MET) has a Form 144 notice covering a planned sale of common stock for the account of a reporting holder.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MetLife (MET) has a Form 144 notice covering a planned sale of common stock for the account of a reporting holder. The filing states that the holder intends to sell 30 shares of common stock through Barclays on the NYSE on or about 11/20/2025, with an aggregate market value of 2242.8. These 30 shares were acquired on 10/11/2021 via a purchase from Citigroup Global Markets, paid in cash on 10/13/2021.
The notice also lists other recent sales of the issuer’s common stock over the past three months by MetLife-related accounts, including 333 shares sold by MetLife 401k Plan Trust-Large Cap Equity Index on 10/01/2025 for gross proceeds of 27282.69 and 196 shares sold by MetLife 401k Plan Russell 1000 Value on 10/29/2025 for 15350.72. The signer represents that they are not aware of undisclosed material adverse information about the issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the MET Form 144 filing disclose about upcoming stock sales?
Which broker and exchange are involved in the MET Form 144 sale?
What recent MET stock sales over the past 3 months are listed in the filing?
What representation does the seller make in the MET Form 144 notice?
AI-generated analysis. How Rhea-AI works. Not financial advice.